Propanc Biopharma, Inc.
PPCB· Nasdaq
Propanc Biopharma, Inc.
- Last sale
- Oct 6, 2026 · +3.92%
- Market cap
- $3.36M
- 6.33M shares
- Filings
- 435
Price
Oct 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Cost of Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2019 | 2019-06-30 | $28,062 | reported | |
| FY 2018 | 2018-06-30 | $30,521 | reported | |
| FY 2017 | 2017-06-30 | $28,992 | reported |
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
